ClearPoint Neuro, Inc.

NasdaqCM CLPT

ClearPoint Neuro, Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2024: -52.52%

ClearPoint Neuro, Inc. Return on Capital Employed (ROCE) is -52.52% for the Trailing 12 Months (TTM) ending September 30, 2024, a -2.79% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

ClearPoint Neuro, Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2023 was -51.10%, a -81.41% change year over year.
ClearPoint Neuro, Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2022 was -28.17%, a -49.30% change year over year.
ClearPoint Neuro, Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2021 was -18.87%.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

NasdaqCM: CLPT

ClearPoint Neuro, Inc.

CEO	Mr. Joseph Michael Burnett
IPO Date	May 22, 2012
Location	United States
Headquarters	120 S. Sierra Avenue
Employees	107
Sector	Healthcare
Industries Medical Instruments 3D Printing Augmented Reality (AR) Autonomous Driving Biotechnology Clinical Trials Defense & Military Robotics

Description

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Key trends

Past 5 years